Irish Medicines Board: second annual report to the Minister for Health and Children on the Blood Transfusion Service Board.
|dc.contributor.author||Irish Medicines Board (IMB)|
|dc.identifier.citation||Irish Medicines Board, 1999. Irish Medicines Board: second annual report to the Minister for Health and Children on the Blood Transfusion Service Board. Dublin: Irish Medicines Board (IMB).||en_GB|
|dc.description||This is the second report to the Minister for Health & Children by the IMB in relation to the BTSB. This report has been produced in response to the recommendations of the Finlay Tribunal. It is based on inspections of the BTSB facilities nationwide and on information provided at joint meetings. The BTSB is undergoing a period of major change with new processes and new facilities being developed which are welcomed. This report, however, focuses on ongoing activities during 1998 and monitors their conformity with current standards of Good Manufacturing Practices (GMPs). Good Manufacturing Practice is that part of Quality Assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use. Hence, GMP non-compliance may result in variability in product quality characteristics which in turn may give rise to safety concerns regarding the products. The report identifies the specific instances of GMP non compliance organised as in the first report in accordance with the relevant EU directive on GMP.||en_GB|
|dc.publisher||Irish Medicines Board (IMB)||en_GB|
|dc.title||Irish Medicines Board: second annual report to the Minister for Health and Children on the Blood Transfusion Service Board.||en_GB|